Sunitinib-associated thrombotic microangiopathy: a significant risk

Clin Oncol (R Coll Radiol). 2014 Aug;26(8):515. doi: 10.1016/j.clon.2014.03.010. Epub 2014 Apr 18.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Clinical Trials, Phase III as Topic
  • Humans
  • Indoles / adverse effects*
  • Indoles / therapeutic use
  • Pyrroles / adverse effects*
  • Pyrroles / therapeutic use
  • Sunitinib
  • Thrombotic Microangiopathies / chemically induced*

Substances

  • Antineoplastic Agents
  • Indoles
  • Pyrroles
  • Sunitinib